Real-world comparative outcomes of US type 2 diabetes patients initiating analog basal insulin therapy

By Davis Keith L.   Tangirala Muralikrishna   Meyers Juliana L.   Wei Wenhui  

Current Medical Research and Opinion, Vol. 29, Iss. 9, 2013-09 ,pp. : 1083-1091

Informa Healthcare

Access to resources Recommend Favorite

Comparison of daily insulin dose and other antidiabetic medications usage for type 2 diabetes patients treated with an analog basal insulin

By McAdam-Marx Carrie   Yu Junhua   Bouchard Jonathan   Aagren Mark   Brixner Diana I.  

Current Medical Research and Opinion, Vol. 26, Iss. 1, 2010-01 ,pp. : 191-201

Informa Healthcare

Access to resources Recommend Favorite

Treat-to-target comparison between once daily biphasic insulin aspart 30 and insulin glargine in Chinese and Japanese insulin-naïve subjects with type 2 diabetes

By Yang Wenying   Xu Xiangjin   Liu Xiaomin   Yang Gangyi   Seino Yutaka   Andersen Henning   Jinnouchi Hideaki  

Current Medical Research and Opinion, Vol. 29, Iss. 12, 2013-12 ,pp. : 1599-1608

Informa Healthcare

Access to resources Recommend Favorite

Insulin detemir: a long-acting insulin analog for the treatment of Type 1 and 2 diabetes

By Meneghini Luigi F  

Therapy, Vol. 5, Iss. 4, 2008-07 ,pp. : 513-529

Future Medicine

Access to resources Recommend Favorite

Biphasic vs basal bolus insulin regimen in Type 2 diabetes: a systematic review and meta‐analysis of randomized controlled trials

By  

DIABETIC MEDICINE, Vol. 32, Iss. 5, 2015-05 ,pp. : 585-594

John Wiley & Sons Inc

Access to resources Recommend Favorite